Stocktwits on MSN
Johnson & Johnson terminates experimental eczema drug study after it fails to show benefit
The drug JNJ-5939 was being evaluated in the treatment of moderate to severe atopic dermatitis in a mid-stage study. ・JNJ, ...
Merchant of misery Yorgos Lanthimos is back to ruin your day again, this time with Bugonia (now streaming on Peacock, in ...
Researchers warn that climate, forest-based livelihoods and weak vector control fuel infections, while stigma and treatment ...
Nemolizumab, which targets the interleukin-31 pathway, rapidly improves itch and sleep in people with atopic dermatitis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results